125459 Apr 2026

For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official .

: Characterizing potential immune responses to the viral vector or the new protein produced by the therapy. 125459

: Assessing the risk of "insertional mutagenesis"—where the therapy might accidentally interfere with the patient's existing DNA. For more detailed technical specifications, you can access